Recombinant Mitogen Activated Protein Kinase Kinase 1 (MAP2K1) Homo sapiens (Human) Recombinant protein

MAPKK1; MEK1; MKK1; PRKMK1; Dual specificity mitogen-activated protein kinase kinase 1; ERK activator kinase 1

  • Product No.RPD559Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationCytoplasm, cytoskeleton, microtubule organizing center, centrosome
  • Predicted Molecular Mass39.0kDa
  • Accurate Molecular Massn/a(Analysis of differences refer to the manual)
  • Residues & TagsLeu54~Val369 (Accession # Q02750) with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point7.0
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 1g In stock
  • FOB US$ 184.00 FREE TRIAL US$ 460.00 FREE TRIAL US$ 920.00 FREE TRIAL US$ 2,760.00 FREE TRIAL US$ 69,000.00 FREE TRIAL
  • Quantity
  • Add to Cart Distributors
  • Recombinant Mitogen Activated Protein Kinase Kinase 1 (MAP2K1) Packages (Simulation)
  • Recombinant Mitogen Activated Protein Kinase Kinase 1 (MAP2K1) Packages (Simulation)
  • RPD559Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered



Reconstitute in PBS or others.


Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.


The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.


  • Graefe's Archive for Clinical and Experimental OphthalmologyRole of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndromepubmed:27538909
  • PLOS ONEIdentification of Biomarkers of Impaired Sensory Profiles among Autistic Patients.pubmed:27824861

Recommend products